コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 effects of many missense mutations of human aspartoacylase.
3 tures revealed that the N-terminal domain of aspartoacylase adopts a protein fold similar to that of
4 myosin-1d interacts and is co-expressed with aspartoacylase, an enzyme that plays a key role in fatty
13 ed perturbed metabolic regulators, including aspartoacylase (Aspa), which facilitates generation of a
14 ethal leukodystrophy caused by deficiency in aspartoacylase (ASPA), which hydrolyzes N-acetylaspartat
19 tested a three-dimensional homology model of aspartoacylase based on zinc dependent carboxypeptidase
22 eviously shown to block brain vacuolation in aspartoacylase-deficient mice, also prevents neuron loss
27 hypothesize that the catalytic mechanism of aspartoacylase is closely analogous to that of carboxype
28 novel explanations for most loss-of-function aspartoacylase mutations associated with Canavan Disease
29 avan disease is caused by inactivating ASPA (aspartoacylase) mutations that prevent cleavage of N-ace
31 (H21E/E24H and E24H/H116E) yielded wild-type aspartoacylase protein levels and undetectable ASPA acti
32 stabilization (R63N) also yielded wild-type aspartoacylase protein levels and undetectable aspartoac
34 stal structures of recombinant human and rat aspartoacylase refined to 2.8- and 1.8-A resolution, res
36 with the Escherichia coli-expressed form of aspartoacylase suggested the need for a suitable eukaryo
37 onserved substrate-determining residues with aspartoacylase that, when mutated, cause Canavan disease
38 malfunctioning of a single metabolic enzyme, aspartoacylase, that catalyzes the deacetylation of N-ac
39 that result in near undetectable activity of aspartoacylase, which catalyzes the deacetylation of N-a
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。